Manufacturing activity in China hit a 13-month high last month, HSBC Holdings PLC said yesteray, in another sign that the world’s second-largest economy is emerging from a drawn-out slumber.
The banking giant’s purchasing managers’ index (PMI) hit 50.5 last month, up from 49.5 in October, putting it above the 50 mark that indicates growth. A reading below signals contraction.
The figure signals a return to growth after 12 consecutive months of contraction as the crucial manufacturing sector has been hit by a global slowdown as well as the debt crisis in key market Europe, where demand for Chinese goods has slumped.
It is the highest reading since October last year, when the figure was 51, HSBC data show.
China’s official PMI reading also showed expansion last month for the second month in a row, hitting 50.6, compared with 50.2 in October and 49.8 in September.
The HSBC index, compiled by information services provider Markit, tracks manufacturing activity and is a closely watched barometer of the health of an economy.
“This confirms the Chinese economy continues to recover gradually,” Hong Kong-based HSBC economist Qu Hongbin (屈宏斌) said.
The bank expects China’s economic growth to pick up modestly to about 8 percent in the fourth quarter as government “easing measures continue to filter through,” he added.
New export orders increased at “a market rate,” with a number of firms linking the rise to a pick-up in demand, particularly in Europe and the US, HSBC said.
Tang Jianwei (唐建偉), a Shanghai-based economist for the Bank of Communications (交通銀行), tipped conditions to further improve next year.
“Next year the economic outlook will be better, especially with the coming of the Chinese New Year when demand will increase. We will likely see steady improvement in PMI in the next few months,” he said.
China’s economic growth hit a more than three-year low of 7.4 percent in the third quarter from July to September.
Yet recent data has fueled optimism that the worst is over. Exports, industrial production, retail sales and fixed asset investment — a key gauge of infrastructure spending — have all shown improvement.
China cut interest rates twice this year and decreased the amount of funds banks must keep in reserve three times since December last year to encourage lending. However, it has avoided the kind of huge stimulus package it tabled after the global financial crisis in 2008 and 2009 which sent inflation soaring.
In related news, China’s new home prices rose the most in four months, as smaller developers marketed more projects amid interest from buyers concerned that prices will start rising again.
Prices climbed for a sixth consecutive month, increasing 0.26 percent to 8,791 yuan (US$1,412) per square meter last month from October, said SouFun Holdings Ltd (搜房控股), China’s biggest real-estate Web site owner, in an e-mailed statement yesterday, based on its survey of 100 cities.
The eastern city of Heze had the biggest gain last month, increasing 1.97 percent, SouFun said. Home prices in Beijing rose 0.7 percent from October and increased 0.1 percent in Shanghai.
“Buyers’ sentiment improved as they saw home sales rise in first-tier cities, which is a leading indicator,” said Johnson Hu, a Hong Kong-based property analyst at CIMB-GK Securities Research (聯昌國際證券). “First-home buyers, who have been waiting and watching the market, are begging to take action in case home prices take off nationwide.”
Gogoro Inc (睿能創意) yesterday launched its first electric bicycle, the Gogoro Eeyo 1, in Taiwan, after unveiling the bike in New York in late May and in France on Tuesday. The company said it would also introduce the series in other European countries such as Germany and the Netherlands. The “Eeyo project” is the fourth of Gogoro’s eight projects that concentrate on smart transportation, which includes Gogoro’s electric scooter, battery swap system and electric scooter sharing service, company founder and chief executive officer Horace Luke (陸學森) told a media briefing in Taipei. “There are various types of city commuters. We will not
EXPERIMENTAL DRUG: While news about a COVID-19 vaccine is more eye-catching, developing a treatment would be more viable, the Senhwa boss said Senhwa Biosciences Inc (生華科) aims to raise NT$1.5 billion (US$50.57 million) by issuing 15 million new common shares in the third quarter of this year to fund the research of new drugs, including the experimental drug Silmitasertib for the treatment of COVID-19, the company said on Monday. That would be the firm’s largest fundraising effort after it raised more than NT$1.4 billion from an initial public offering on the Taipei Exchange (TPEX) in April 2017, chief financial officer Sarah Chang (張小萍) told the Taipei Times by telephone. The price of the new shares would depend on the firm’s average share price
NOT A PANACEA: Offering 5G services would not solve the problem of declining telecom incomes, chairman Sheih Chi-mau said, expecting a flat 5G telecom revenue Chunghwa Telecom Co (中華電信) yesterday became the nation’s first telecom to debut its 5G services, offering tiered tariffs that include a threshold of NT$599 and flat rates, as it aims to switch half of its subscribers to the 5G network within three years. Subscribers would have unlimited data transmission for monthly fees starting at NT$1,399 — the same flat rate as when the company launched its 4G service in 2014 — and they can subscribe to the highest-rate plan for NT$2,699 per month for faster data transmission speeds and larger bandwidth, the company said. Data transmission speeds would be within the range
STAYING AHEAD: TSMC expects its sales this year to grow 14 to 19 percent and could spend up to US$3.52 billion on research and development, leaving its rivals far behind Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) reported that the US last year approved 99 percent of its patent applications, which placed the tech giant among the top patent holders in the US. In its Corporate Social Responsibility Report, TSMC said it last year secured about 3,600 patents worldwide, including more than 2,300 in the US. As of the end of last year, TSMC owned more than 39,000 patents, the report said. The company last year filed almost 6,500 patent applications worldwide and ranked among the top 10 patent applicants in the US. In Taiwan, it was the largest patent applicant for the fourth